Lupin Limited (NSE:LUPIN)
1,943.80
+3.80 (0.20%)
Oct 20, 2025, 3:29 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 888.28 billion as of October 20, 2025. Its market cap has decreased by -11.09% in one year.
Market Cap
888.28B
Enterprise Value
913.77B
Revenue
233.76B
Ranking
n/a
PE Ratio
24.01
Stock Price
1,943.80
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 888.28B, an increase of 88,893.67%. That is a compound annual growth rate of 29.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 885.58B | -17.43% |
Dec 31, 2024 | 1.07T | 78.05% |
Dec 29, 2023 | 602.42B | 80.75% |
Dec 30, 2022 | 333.29B | -22.86% |
Dec 31, 2021 | 432.05B | -2.46% |
Dec 31, 2020 | 442.95B | 27.89% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 4.03T |
Divi's Laboratories | 1.76T |
Cipla | 1.27T |
Apollo Hospitals Enterprise | 1.14T |
Mankind Pharma | 1.02T |
Zydus Lifesciences | 993.81B |
Fortis Healthcare | 819.05B |
Alkem Laboratories | 667.35B |